Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2020.01256
PubMed Identifier: 32625215
Publication URI: http://europepmc.org/abstract/MED/32625215
Type: Journal Article/Review
Volume: 11
Parent Publication: Frontiers in immunology
ISSN: 1664-3224